Inventor · disambiguated record
Patrick Beaulieu
Also filed as: BEAULIEU PATRICK
5 granted patents·7 pending applications·22 citations·filing 2006–2022
73Inventor score
Files withREPARE THERAPEUTICS INC3DEZIEL ROBERT2FORUM PHARMACEUTICALS INC2METHYLGENE INC2GALLANT MICHEL1
Top patents by PatentIndex Score
12 records- 0182US8673911B2Inhibitors of histone deacetylaseMALLAIS TAMMY·Filed 2008·Granted Mar 18, 2014·13 cites·2 claims
- 0281US9328138B2HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2012·Granted May 3, 2016·8 cites·17 claims
- 0366US8399452B2Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitorsDEZIEL ROBERT·Filed 2007·Granted Mar 19, 2013·1 cites·52 claims
- 0459US9193749B2Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitorsFORUM PHARMACEUTICALS INC·Filed 2013·Granted Nov 24, 2015·0 cites·2 claims
- 0552US12435090B2Compounds, pharmaceutical compositions, and methods of preparing compounds and of their useREPARE THERAPEUTICS INC·Filed 2022·Granted Oct 7, 2025·0 cites·10 claims
- 0650US2016222026A1Dibenzo[B,F][1,4]oxazepin-11-yl-N-Hydroxybenzamides as HDAC InhibitorsFORUM PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 0747US2014045850A1Inhibitors of histone deacetylaseMETHYLGENE INC·Filed 2013·Application pending·0 cites
- 0846US2011196147A1Inhibitors of histone deacetylaseDEZIEL ROBERT·Filed 2011·Application pending·0 cites
- 0944US2023158022A1Methods of using myt1 inhibitorsREPARE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1043US2023151014A1Compounds, pharmaceutical compositions, and methods of preparing compounds and of their useREPARE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1142US2013244929A1Bridged lipoglycopeptides that potentiate the activity of beta-lactam antibacterialsGALLANT MICHEL·Filed 2011·Application pending·0 cites
- 1238US2006264415A1Inhibitors of histone deacetylaseMETHYLGENE INC·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Patrick Beaulieu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →